Autor: |
Nath, Sukanta, Bhattacharyya, Jina, Chandra, Prem, Saxena, Renu, Sazawal, Sudha, Kumar, Kandarpa |
Zdroj: |
Hematology/Oncology and Stem Cell Therapy; 20240101, Issue: Preprints |
Abstrakt: |
Acute myeloid leukemia (AML) is one of the common forms of hematological malignancy and acute promyelocytic leukemia (APL) is a unique subtype of AML conferring favorable prognosis. We aimed to determine the prevalence and prognostic impact of Fms-like tyrosine kinase 3 (FLT3), nucleophosmin 1 (NPM1) mutation, epidermal growth factor receptor (EGFR), and flow marker’s expression in patients with APL. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|